| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ji Hwan Kim, Jonghu Jeon, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Ki. Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease. Clinical nuclear medicine. vol 48. issue 2. 2023-01-06. PMID:36607363. |
striatal dopaminergic loss and dysphagia in parkinson disease. |
2023-01-06 |
2023-08-14 |
Not clear |
| Bohye Kim, Poornima D E Weerasinghe-Mudiyanselage, Mary Jasmin Ang, Jeongmin Lee, Sohi Kang, Jong-Choon Kim, Sung-Ho Kim, Joong-Sun Kim, Chaeyong Jung, Taekyun Shin, Changjong Moo. Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease. International neurourology journal. vol 26. issue Suppl 2. 2022-12-12. PMID:36503212. |
parkinson disease (pd) is a progressive neurodegenerative disorder in which dopaminergic (daergic) systems are destroyed (particularly in the nigrostriatal system), causing both motor and nonmotor symptoms. |
2022-12-12 |
2023-08-14 |
rat |
| Francisco Navarro-Lozano, Pawel Kiper, Cristina Carmona-Pérez, Sebastian Rutkowski, Elena Pinero-Pinto, Carlos Luque-Moren. Effects of Non-Immersive Virtual Reality and Video Games on Walking Speed in Parkinson Disease: A Systematic Review and Meta-Analysis. Journal of clinical medicine. vol 11. issue 22. 2022-11-26. PMID:36431086. |
people with parkinson disease suffer from a loss of dopaminergic neurons, which are involved in walking speed. |
2022-11-26 |
2023-08-14 |
human |
| Zohra Rahmani, Satya Surabhi, Francisca Rojo-Cortés, Amina Dulac, Andreas Jenny, Serge Birma. International journal of molecular sciences. vol 23. issue 21. 2022-11-11. PMID:36361864. |
parkinson disease (pd) is a common neurodegenerative condition affecting people predominantly at old age that is characterized by a progressive loss of midbrain dopaminergic neurons and by the accumulation of α-synuclein-containing intraneuronal inclusions known as lewy bodies. |
2022-11-11 |
2023-08-14 |
Not clear |
| Jiahui Shao, Xuan Liu, Mengjia Lian, Youbing Ma. Citronellol Prevents 6-OHDA-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Parkinson Disease Model of SH-SY5Y Cells via Modulating ROS-NO, MAPK/ERK, and PI3K/Akt Signaling Pathways. Neurotoxicity research. 2022-09-13. PMID:36097250. |
parkinson disease is a neurodegenerative disorder distinguished by dopaminergic shortage in the striatum and the accumulation of α-synuclein neuronal aggregates in the brains of patients. |
2022-09-13 |
2023-08-14 |
Not clear |
| Rayan Fakih, Véronique Sauvé, Kalle Gehrin. Feedforward activation of PRKN/parkin. Autophagy. 2022-07-15. PMID:35838500. |
parkinson disease is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the midbrain. |
2022-07-15 |
2023-08-14 |
Not clear |
| Devdutta S Warhadpande, Jiayan Huo, William A Libling, Carol Stuehm, Bijan Najafi, Scott Sherman, Hong Lei, Janet Meiling Roveda, Phillip H Ku. Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome. Sensors (Basel, Switzerland). vol 22. issue 13. 2022-07-09. PMID:35808551. |
parkinson disease (pd) is the second most common neurodegenerative disorder with loss of dopaminergic neurons of the substantia nigra and, thus, dysfunction of the nigrostriatal pathway. |
2022-07-09 |
2023-08-14 |
Not clear |
| Taiwo G Olubodun-Obadun, Ismail O Ishola, Olufunmilayo O Adeyem. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease. Drug metabolism and personalized therapy. vol 37. issue 2. 2022-06-23. PMID:35737301. |
parkinson disease (pd) is a progressive neurodegenerative movement disorder characterized by motor and non-motor symptoms due to loss of striatal dopaminergic neurons and disruption of degradation signaling leading to the formation of lewy bodies (aggregation of α-synuclein). |
2022-06-23 |
2023-08-14 |
Not clear |
| Elon D Wallert, Elsmarieke van de Giessen, Remco J J Knol, Martijn Beudel, Rob M A de Bie, Jan Booi. Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 63. issue Suppl 1. 2022-06-01. PMID:35649651. |
imaging of dopaminergic transmission in neurodegenerative disorders such as parkinson disease (pd) or dementia with lewy bodies plays a major role in clinical practice and in clinical research. |
2022-06-01 |
2023-08-13 |
Not clear |
| Maira Ayaz, Fareeha Anwar, Uzma Saleem, Irum Shahzadi, Bashir Ahmad, Ali Mir, Tariq Ismai. Parkinsonism Attenuation by Antihistamines via Downregulating the Oxidative Stress, Histamine, and Inflammation. ACS omega. vol 7. issue 17. 2022-05-13. PMID:35557705. |
parkinson disease (pd) is a neurodegenerative disorder of the motor activity of the brain, regulated by dopaminergic neurons of substantia nigra, resulting in an increased density of histaminergic fibers. |
2022-05-13 |
2023-08-13 |
Not clear |
| Zi H Su, Salil Patel, Bronwyn Gavine, Tim Buchanan, Marko Bogdanovic, Nagaraja Sarangmat, Alexander L Green, Bastiaan R Bloem, James J FitzGerald, Chrystalina A Antoniade. Deep Brain Stimulation and Levodopa Affect Gait Variability in Parkinson Disease Differently. Neuromodulation : journal of the International Neuromodulation Society. 2022-05-13. PMID:35562261. |
both dopaminergic medication and subthalamic nucleus (stn) deep brain stimulation (dbs) can improve the amplitude and speed of gait in parkinson disease (pd), but relatively little is known about their comparative effects on gait variability. |
2022-05-13 |
2023-08-13 |
Not clear |
| Hye-Sun Lim, Gunhyuk Par. Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models. Neuroscience letters. 2022-05-01. PMID:35490904. |
resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in parkinson disease models. |
2022-05-01 |
2023-08-13 |
mouse |
| Paula Trujillo, Alexander K Song, Kaitlyn R Hay, Megan Aumann, Yan Yan, Hakmook Kang, Manus J Donahue, Daniel O Claasse. Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients. NPJ Parkinson's disease. vol 8. issue 1. 2022-04-06. PMID:35383185. |
in parkinson disease (pd), dopaminergic therapies can result in the development of impulsive and compulsive behaviors, and this clinical syndrome shares similar pathophysiology to that seen in addiction, substance abuse, and binge-eating disorders. |
2022-04-06 |
2023-08-13 |
Not clear |
| Carlos A Sanchez-Catasus, Nicolaas I Bohnen, Nicholas D'Cruz, Martijn L T M Mülle. Striatal Acetylcholine-Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET-Informed Correlational Tractography. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 63. issue 3. 2022-03-29. PMID:34272323. |
striatal acetylcholine-dopamine imbalance in parkinson disease: in vivo neuroimaging study with dual-tracer pet and dopaminergic pet-informed correlational tractography. |
2022-03-29 |
2023-08-16 |
Not clear |
| Myung Jun Lee, Kyoungjune Pak, Han-Kyeol Kim, Kelly N Nudelman, Jong Hun Kim, Yun Hak Kim, Junho Kang, Min Seok Baek, Chul Hyoung Lyo. Author Correction: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease. NPJ Parkinson's disease. vol 8. issue 1. 2022-03-10. PMID:35264601. |
author correction: genetic factors affecting dopaminergic deterioration during the premotor stage of parkinson disease. |
2022-03-10 |
2023-08-13 |
Not clear |
| Agnes Langer, Lara Lucke-Paulig, Lucia Gassner, Rejko Krüger, Daniel Weiss, Alireza Gharabaghi, Heidemarie Zach, Walter Maetzler, Markus A Hober. Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-duration Deep Brain Stimulation. Neuromodulation : journal of the International Neuromodulation Society. 2022-03-01. PMID:35227581. |
additive effect of dopaminergic medication on gait under single and dual-tasking is greater than of deep brain stimulation in advanced parkinson disease with long-duration deep brain stimulation. |
2022-03-01 |
2023-08-13 |
Not clear |
| Igor Straka, Michal Minar, Milan Grofik, Matej Skorvanek, Veronika Bolekova, Andrea Gazova, Jan Kyselovic, Peter Valkovi. Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications. Journal of personalized medicine. vol 12. issue 2. 2022-02-25. PMID:35207667. |
effect of pillbox organizers with alarms on adherence to pharmacotherapy in parkinson disease patients taking three and more daily doses of dopaminergic medications. |
2022-02-25 |
2023-08-13 |
Not clear |
| Jee-Young Lee, Antonio Martin-Bastida, Ane Murueta-Goyena, Iñigo Gabilondo, Nicolás Cuenca, Paola Piccini, Beomseok Jeo. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nature reviews. Neurology. 2022-02-18. PMID:35177849. |
multimodal brain and retinal imaging of dopaminergic degeneration in parkinson disease. |
2022-02-18 |
2023-08-13 |
Not clear |
| Jee-Young Lee, Antonio Martin-Bastida, Ane Murueta-Goyena, Iñigo Gabilondo, Nicolás Cuenca, Paola Piccini, Beomseok Jeo. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nature reviews. Neurology. 2022-02-18. PMID:35177849. |
parkinson disease (pd) is a progressive disorder characterized by dopaminergic neurodegeneration in the brain. |
2022-02-18 |
2023-08-13 |
Not clear |
| Kasthuri Bai Magalingam, Sushela Devi Somanath, Shadab Md, Nagaraja Haleagrahara, Ju-Yen Fu, Kanga Rani Selvaduray, Ammu Kutty Radhakrishna. Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression. Nutrition research (New York, N.Y.). vol 98. 2022-01-22. PMID:35065349. |
oxidative stress is a critical factor that triggers a "domino" cascade of events leading to the degeneration of dopaminergic neurons in parkinson disease. |
2022-01-22 |
2023-08-13 |
human |